Riverpoint Medical, LLC
USPTO PatentsView assignee record - 58 granted patents across 19 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Riverpoint ranks #5,876 of 49,997 tracked US assignees by granted-patent volume, with 58 patents across 19 technology areas.
- #5,876
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (41.0/100)
- 11.7
- avg claims per patent
- +59%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5876 · US Corporation #5,876 · 58 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 58 grants
- UPPER-Q #5,876/49,997
- PHOTO-FINISH RareCyte
- CPC-FOCUS A61B · 19 areas
- INNOV-PAR 41.0/100
- CLAIMS-PAR 11.7 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +59% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: RareCyte, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Riverpoint’s 41.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Riverpoint
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Contec · near
Contec · near
41 score
- Meiji Seika Pharma · near
Meiji Seika Pharma · near
41 score
- MiniPumps · near
MiniPumps · near
41 score
- Riverpoint Medical · this assignee
Riverpoint Medical · this assignee
41 score
- Senvion · near
Senvion · near
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Riverpoint's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Riverpoint?
Each dot is one of Riverpoint’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Riverpoint’s own 11.7 claims/patent is ABOVE the 7.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Riverpoint's grants concentrate
Riverpoint Medical, LLC is a focused PatentsView assignee: 19 CPC subclasses with 82.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (10 grants) versus a trough of 2 in 2015. By volume, Riverpoint sits between Riken Technos Corporation and Soft Robotics, Inc..
Riverpoint's three-year grant acceleration
From 2019–2021 to 2022–2024, Riverpoint Medical, LLC moved from 24 to 16 grants (0.67x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Riverpoint's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Riken Technos
Riken Technos Corporation
58 patents
- Rtic IP
Rtic IP, LLC
58 patents
- Rarecyte
RareCyte, Inc.
58 patents
- Real Value
Real Value LLC
58 patents
- Sakata INX
Sakata INX Corporation
58 patents
- Sami Labs
Sami Labs Limited
58 patents
- Seoul National Un…
Seoul National University Hospital
58 patents
- Soft Robotics
Soft Robotics, Inc.
58 patents
- Riverpoint Medical ◀
Riverpoint Medical, LLC
58 patents
What this shows Riverpoint holds 58 patents at rank #5,877, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Riverpoint
By rank, the assignees closest to #5,877 in granted patent volume.
- Riken Technos Corporation #5,873 · 58 patents
- Rtic IP, LLC #5,874 · 58 patents
- RareCyte, Inc. #5,875 · 58 patents
- Real Value LLC #5,876 · 58 patents
- Sakata INX Corporation #5,878 · 58 patents
- Sami Labs Limited #5,879 · 58 patents
- Seoul National University Hospital #5,880 · 58 patents
- Soft Robotics, Inc. #5,881 · 58 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Riverpoint's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Riverpoint, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Riverpoint ranks #391 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (41 here).
Similar claim depth
Nearest assignees by average claims per patent (11.7 here).
Riverpoint's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 3.4% |
| 2016 | 6 | 10.3% |
| 2017 | 7 | 12.1% |
| 2018 | 2 | 3.4% |
| 2019 | 5 | 8.6% |
| 2020 | 10 | 17.2% |
| 2021 | 9 | 15.5% |
| 2022 | 7 | 12.1% |
| 2023 | 6 | 10.3% |
| 2024 | 3 | 5.2% |
| 2025partial year | 1 | 1.7% |
Which technologies does Riverpoint Medical, LLC patent most?
Top 15 of 19 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Riverpoint Medical, LLC's patent record in context - here's where to go next.
- Riverpoint Medical, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 82.8% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #5,876 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Riverpoint Medical, LLC against Riken Technos Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 41.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.